Srpski arhiv za celokupno lekarstvo 2023 Volume 151, Issue 3-4, Pages: 255-258
https://doi.org/10.2298/SARH221212008M
Full text (
166 KB)
Cited by
Historical and statistical aspects of risk groups analysis and testing in the context of gestational diabetes mellitus
Macura Maja 
(University Clinical Centre of Serbia, Clinic for Gynecology and Obstetrics, Belgrade, Serbia + University of Belgrade, Faculty of Medicine, Belgrade, Serbia)
Dugalić Stefan (University Clinical Centre of Serbia, Clinic for Gynecology and Obstetrics, Belgrade, Serbia + University of Belgrade, Faculty of Medicine, Belgrade, Serbia)
Todorović Jovana (University of Belgrade, Faculty of Medicine, Institute of Social Medicine, Belgrade, Serbia), jovana.todorovic@med.bg.ac.rs
Gutić Bojana (University of Novi Sad, Institute of Oncology of Vojvodina, Clinic for Operative Oncology; Novi Sad, Serbia)
Milinčić Miloš (University of Belgrade, Faculty of Medicine, Belgrade, Serbia;)
Božić Dragana (University Clinical Centre of Serbia, Clinic for Gynecology and Obstetrics, Belgrade, Serbia)
Stojiljković Milica (University of Belgrade, Faculty of Medicine, Institute of Medical Statics and Informatics, Belgrade, Serbia)
Soldatović Ivan (University of Belgrade, Faculty of Medicine, Institute of Medical Statics and Informatics, Belgrade, Serbia)
Pantić Igor (University of Belgrade, Faculty of Medicine, Institute of Medical Physiology, Belgrade, Serbia)
Perović Milan (University of Belgrade, Faculty of Medicine, Belgrade, Serbia + Narodni front University Clinic for Gynecology and Obstetrics, Belgrade, Serbia)
Parapid Biljana (University of Belgrade, Faculty of Medicine, Belgrade, Serbia + University Clinical Centre of Serbia, Division of Cardiology, Belgrade, Serbia)
Gojnić Miroslava (University Clinical Centre of Serbia, Clinic for Gynecology and Obstetrics, Belgrade, Serbia + University of Belgrade, Faculty of Medicine, Belgrade, Serbia)
In order to enhance cost-benefit value of the gestational diabetes mellitus screening (GDM) the concept of universal screening i.e., screening of all pregnant women for gestational diabetes, has mostly been abandoned in favor of the concept of selective screening. Selective screening implies that only women with risk factors are being screened for GDM. However, some recent studies have shown that with the application of the selective screening approach, some women with GDM may not receive proper and timely diagnosis. This review addresses the pros and cons of both concepts. It will also discuss screening methods and methods of preparation and performance of oral glucose tolerance test and the interpretation of its results.
Keywords: gestational diabetes mellitus, universal screening, selective screening, oral glucose tolerance
Show references
Gojnic Dugalic M., et al. Diabetes i trudnoća. Medicinski fakultet Univerziteta u Beogradu: Novo doba, 2012.
Benhalima K, Van Crombrugge P, Moyson C, Verhaeghe J, Vandeginste S, Verlaenen H, et al. Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria. Eur J Endocrinol. 2019;180(6):353-63. [DOI: 10.1530/EJE-19-0117] [PMID: 31120231]
Committee ADAPP. 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2021;45(Supplement_1):S232-43. [DOI: 10.2337/dc22-S015] [PMID: 34964864]
Li X, Liu X, Zuo Y, Gao J, Liu Y, Zheng W. The risk factors of gestational diabetes mellitus in patients with polycystic ovary syndrome: What should we care. Medicine (Baltimore). 2021;100(31):e26521. [DOI: 10.1097/MD.0000000000026521] [PMID: 34397795]
Miller C, Lim E. The risk of diabetes after giving birth to a macrosomic infant: data from the NHANES cohort. Matern Heal Neonatol Perinatol. 2021;7(1):12. [DOI: 10.1186/s40748-021-00132-8] [PMID: 33980302]
Bashir M, Ibrahim I, Eltaher F, Beer S, Baagar K, Aboulfotouh M, et al. Screening pregnant women in a high-risk population with WHO-2013 or NICE diagnostic criteria does not affect the prevalence of gestational diabetes. Sci Rep. 2021;11(1):5604. [DOI: 10.1038/s41598-021-84918-y] [PMID: 33692395]
Liao LD, Ferrara A, Greenberg MB, Ngo AL, Feng J, Zhang Z, et al. Development and validation of prediction models for gestational diabetes treatment modality using supervised machine learning: a population-based cohort study. BMC Med. 2022;20(1):307. [DOI: 10.1186/s12916-022-02499-7] [PMID: 36104698]
Alexopoulos AS, Blair R, Peters AL. Management of Preexisting Diabetes in Pregnancy: A Review. JAMA. 2019;321(18):1811-9. [DOI: 10.1001/jama.2019.4981] [PMID: 31087027]
Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med. 2002 ;19(4):322-6. [DOI: 10.1046/j.1464-5491.2002.00700.x] [PMID: 11943005]
Behboudi-Gandevani S, Bidhendi-Yarandi R, Panahi MH, Vaismoradi M. The Effect of Mild Gestational Diabetes Mellitus Treatment on Adverse Pregnancy Outcomes: A Systemic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021;1212:640004. [DOI: 10.3389/fendo.2021.640004] [PMID: 33841332]
Mendes N, Alves M, Andrade R, Ribeiro RT, Papoila AL, Serrano F. Association between glycated albumin, fructosamine, and HbA1c with neonatal outcomes in a prospective cohort of women with gestational diabetes mellitus. Int J Gynaecol Obstet. 2019;146(3):326-32. [DOI: 10.1002/ijgo.12897] [PMID: 31242319]
Cheung NW, Jiang S, Athayde N. Impact of the IADPSG criteria for gestational diabetes, and of obesity, on pregnancy outcomes. Aust N Z J Obstet Gynaecol. 2018;58(5):553-9. [DOI: 10.1111/ajo.12772] [PMID: 29359312]
Fitria N, van Asselt ADI, Postma MJ. Cost-effectiveness of contolling gestational diabetes mellitus: a systematic review. Eur J Health Econ. 2019;20(3):407-17. [DOI: 10.1007/s10198-018-1006-y] [PMID: 30229375]
Coustan DR, Widness JA, Carpenter MW, Rotondo L, Pratt DC, Oh W. Should the fifty-gram one-hour glucose screening test for gestational diabetes be administered in the fasting or fed state? Am J Obstet Gynecol. 1986;154(5):1031-5. [DOI: 10.1016/0002-9378(86)90744-1] [PMID: 3706427]
Maulik D, Lysikiewicz A, Sicuranca G. Umbilical arterial Doppler sonography for fetal surveillance in pregnancies complicated by pregestational diabetes mellitus. J Matern Fetal Neonatal Med. 2002;12(6):417-22. [DOI: 10.1080/jmf.12.6.417.422] [PMID: 12683654]
Benhalima K, Van Crombrugge P, Moyson C, Verhaeghe J, Vandeginste S, Verlaenen H, et al. Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria. Eur J Endocrinol. 2019;180(6):353-63. [DOI: 10.1530/EJE-19-0117] [PMID: 31120231]
Vitacolonna E, Succurro E, Lapolla A, Scavini M, Bonomo M, Di Cianni G, et al. Guidelines for the screening and diagnosis of gestational diabetes in Italy from 2010 to 2019: critical issues and the potential for improvement. Acta Diabetol. 2019;56(11):1159- 67. [DOI: 10.1007/s00592-019-01397-4] [PMID: 31396699]
Kattini R, Hummelen R, Kelly L. Early Gestational Diabetes Mellitus Screening With Glycated Hemoglobin: A Systematic Review. J Obstet Gynaecol Can. 2020;42(11):1379-84. [DOI: 10.1016/j.jogc.2019.12.015] [PMID: 32268994]
Nwali SA, Onoh RC, Dimejesi IB, Obi VO, Jombo SE, Edenya OO. Universal versus selective screening for gestational diabetes mellitus among antenatal clinic attendees in Abakaliki: using the one-step 75 gram oral glucose tolerance test. BMC Pregnancy Childbirth. 2021;21(1):735. [DOI: 10.1186/s12884-021-04168-8] [PMID: 34715805]
American Diabetes Association. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 Jan;43(Suppl 1):S183-S192. [DOI: 10.2337/dc20-S014] [PMID: 31862757]
Minschart C, Beunen K, Benhalima K. An Update on Screening Strategies for Gestational Diabetes Mellitus: A Narrative Review. Diabetes, Metab Syndr Obes. 2021;14:3047-76. [DOI: 10.2147/DMSO.S287121] [PMID: 34262311]
O’Sullivan JB, Mahan C. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964;13:278-85. [PMID: 14166677]
Bonomo M, Gandini ML, Mastropasqua A, Begher C, Valentini U, Faden D, et al. Which cutoff level should be used in screening for glucose intolerance in pregnancy? Am J Obstet Gynecol. 1998;179(1):179-85. [DOI: 10.1016/s0002-9378(98)70270-4] [PMID: 9704785]
Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768-73. [DOI: 10.1016/0002-9378(82)90349-0] [PMID: 7148898]
Berger H, Mathew S. Counterpoint: Selective Screening for Gestational Mellitus. 2009;32(7):1352-4. [DOI: 10.2337/dc09-0361] [PMID: 19564480]
Sert UY, Ozgu-Erdinc AS. Gestational Diabetes Mellitus Screening and Diagnosis. Adv Exp Med Biol. 2021;1307:231-55. [DOI: 10.1007/5584_2020_512] [PMID: 32314318]
Montagna M, Lippi G, Targher G, Fava C, Guidi GS. Glucose Challenge Test Does Not Predict Gestational Diabetes Mellitus. Inter Med. 2008;47(13):1171-4. [DOI: 10.2169/internalmedicine.47.0930] [PMID: 18591836]
Lindsay MK, Graves W, Klein L. The relationship of one abnormal blood glucose tolerance test value and pregnancy complications. Obstet Gynecol. 1989;73(1):103-6. [PMID: 2909030]
Succurro E, Fraticelli F, Franzago M, Fiorentino TV, Andreozzi F, Vitacolonna E, et al. Hyperglycemia at 1h-OGTT in Pregnancy: A Reliable Predictor of Metabolic Outcomes? Front Endocrinol (Lausanne). 2021;12:612829. [DOI: 10.3389/fendo.2021.612829] [PMID: 34108933]